Cite
Franklyn AM, Eibl JK, Gauthier G, et al. Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm Reduct J. 2017;14(1):15doi: 10.1186/s12954-017-0140-7.
Franklyn, A. M., Eibl, J. K., Gauthier, G., Pellegrini, D., Lightfoot, N. E., & Marsh, D. C. (2017). Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm reduction journal, 14(1), 15. https://doi.org/10.1186/s12954-017-0140-7
Franklyn, Alexandra M, et al. "Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario." Harm reduction journal vol. 14,1 (2017): 15. doi: https://doi.org/10.1186/s12954-017-0140-7
Franklyn AM, Eibl JK, Gauthier G, Pellegrini D, Lightfoot NE, Marsh DC. Erratum to: The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm Reduct J. 2017 Mar 28;14(1):15. doi: 10.1186/s12954-017-0140-7. PMID: 28351357; PMCID: PMC5369184.
Copy
Download .nbib